F-Prime Capital

??? In the latest episode of The BioHub Podcast, host Max Brennan, MSc connects with our own Martin Taylor, Ph.D., a Senior Associate at F-Prime Capital based in our London office. ? Martin shares his journey from the lab to venture capital, offering a unique perspective on his work at F-Prime, and his thoughts on the future of biotech. ? The BioHub Podcast is known for their in-depth conversations with the top minds in biotech, sharing valuable observations, innovative strategies, and compelling stories from across the industry. ? To listen to the full episode with Martin, please visit the link in comments. ? #TheBioHub #Podcast #Biotech #VentureCapital

Congratulations to Daniel Ives, Ph.D., Brendan Swain, PhD, Ph.D., and the entire Shift Bioscience team on successful completion of your Seed funding. ? The investment will accelerate the development of Shift Bioscience's AI cell simulation platform, enabling the identification of novel gene combinations for the safe reprogramming and rejuvenation of cells affected by age-related illnesses. Additionally, the funding will support the creation of an IP portfolio for the novel rejuvenation factors identified by Shift Bioscience. ? “Our technology is addressing the current limitations of cellular reprogramming for treatment of age-related illnesses,” Dr. Daniel Ives, CEO, Shift Bioscience, commented. “This investment is indicative of the strength of our approach and is one of the earliest funding rounds for a biotech start-up exclusively focused on the rapidly emerging field of cell simulation for target discovery. This additional funding will allow us to accelerate the development of our platform and bring cell rejuvenation therapeutics closer towards clinical trial.” ? Learn more by clicking the link in comments. BGF │ Kindred Capital VC │ Jonathan Milner Alex Pasteur, Ph.D. │ Martin Taylor, Ph.D. │ Anastasiya Sybirna, PhD #Healthcare #AI #BioTech

Boston Fintech Week is officially underway! You'll see us there all week, including: - Sarah Lamont presenting our State of Banking report on Wednesday - David Jegen, Rocio Wu, and Abdul Abdirahman at a lunch & learn with the MIT and HBS Fintech & VC Clubs on Thursday - Sarah at a Thursday roundtable on navigating the funding landscape - A Fintech-specific Female Funders & Founders breakfast on Friday - Our annual Fintech After Dark party, which we're hosting with our friends at Underscore VC and SVB (past parties pictured below) Huge shout out to Fintech Sandbox for all your hard work —?check out the full BFTW agenda via the link in the comments!

What a wonderful evening we had last night at UNI in Boston for the second dinner of our Prime Time event series! ? Over Asian-inspired dishes and inspired cocktails, Alexander Munoz, MD, and Raj Basak, Ph.D., brought together a distinguished group of healthcare investors from the pre-partner community, fostering valuable connections and conversations about the latest trends and insights in biotech and medicine. ? Thank you to everyone who participated and contributed to making the evening a memorable success. Looking forward to more great conversations ahead! ? Alex Wong #Healthcare #BioTech #VentureCapital

Earlier this week we co-hosted an event with the Harvard Undergraduate Venture Capital Group that featured an engaging panel discussion with our own Jessica Alston, Ph.D, as well as, Paul English, the founder of KAYAK and Boston Venture Studio, and Charlie Attlan, a Senior VP of Business Development at Boston Scientific. ? The event was held in a packed auditorium at Harvard University and was open to all undergraduate and graduate students from the Greater Boston Area with an interest in venture and entrepreneurship. The topics of discussion ranged from their journeys into investing and venture capital to their professional backgrounds, and even recommendations to their younger selves. Jess advised attendees to “think more broadly” while in this phase of their lives, urging them to make the most of the opportunities their universities provide and embrace the experience of trying—and sometimes failing—at new things. ? #VentureCapital #PersonalDevelopment #CareerAdvice?

Congratulations to David Baker, Co-Founder of Sana Biotechnology, Inc., Xaira Therapeutics, and CHARM Therapeutics, on being awarded the 2024 Nobel Prize in Chemistry “for computational protein design.” ? David’s groundbreaking work in protein engineering, developing methods to predict and design protein structures through computational modeling, is transforming the field, and we’re proud to support his ongoing efforts through our portfolio companies. ? Learn more by clicking the link in comments. ? #NobelPrize #Biotech #HealthcareInnovation?

Congratulations to Brijraj Bhuptani, Riyaz Rehman, and the entire SPRY team on securing your latest round of funding. SPRY is a SaaS practice management platform designed specifically for physical therapists, integrating clinical, financial, and administrative functions to streamline operations, enhance patient engagement, and automate complex billing processes. Through their latest round of funding, SPRY will be looking to build additional products for the global market in addition to expanding their U.S. sales and servicing team. Learn more by clicking the link in comments. Flourish Ventures │ Together Fund │ Eight Roads Carl Bradford Byers ?? #healthcare #physicaltherapy #healthtech

Attention #biotech entrepreneurs and researchers!? ? Don’t miss your chance to pitch your #startup ideas at #Science2Startup 2025 to top biotech and #pharma executives, VCs, and entrepreneurs in the Boston area.?? ? Applications are due Friday, November 15th: https://lnkd.in/e7bPwMzX??

Last week, we hosted our second F-Prime/FBRI workshop of 2024 focused on Alzheimer’s Disease and Related Disorders in Rhode Island. The event brought together leading experts in neuroscience and related fields to collaborate, exchange insights, and examine the latest advancements in understanding and treating neurological disorders. Stacie Weninger, Ph.D., President of FBRI and Venture Partner at F-Prime Capital, alongside Matthew Boersma, Ph.D., Associate Director at FBRI, led the event, where attendees explored the biology of protein aggregates and mixed pathologies in neurodegeneration. Thank you to all attendees for joining us and contributing their valuable insights to the discussions. #Alzheimers #Neuroscience #Healthcare Stephen Knight, M.D. │ Robert Weisskoff. Ph.D. │ Raj Basak, Ph.D. │ Davina Magargal

Congratulations to Kris Engskov and the entire Rippl team on closing your Series A! Rippl's latest round of funding will help support their efforts to expand their geographic footprint, incorporate new payment models, and advance their AI and technology roadmap. Rippl provides virtual healthcare for seniors, focusing on supporting people with dementia to stay healthy at home and reduce hospital visits by offering comprehensive care and resources for families. Learn more by clicking the link in comments. Tina Hoang-To │ ARCH Venture Partners │ General Catalyst │ GV (Google Ventures) │ Mass General Brigham Ventures │ 1843 Capital │ JSL Health Capital Jon Lim │ Brett Cook #healthcare #dementia #virtualcare